Tan H P, Lebeck L K, Nehlsen-Cannarella S L
Immunology Center, Loma Linda University, School of Medicine, California 92354.
J Leukoc Biol. 1992 Jul;52(1):115-8. doi: 10.1002/jlb.52.1.115.
The discovery of immunoglobulin E (IgE) is considered the most important contribution, to date, in the field of clinical allergy. Studies in rodents and humans have suggested that IgE production could be regulated by antigen-specific helper and suppressor T cells and by isotype-specific factors having affinity for IgE. In recent years, the synthesis of IgE has been shown to be regulated, in part, by a cytokine network. This review summarizes the cytokines that up-regulate (interleukins-4, 5, and 6) and down-regulate (interferon-gamma and interleukin-2) the production of IgE. Emphasis is placed on IL-4 and IFN-gamma, two lymphokines known to play a major, but reciprocal, role in IgE synthesis. Increased insight into the various mechanisms of IgE control by cytokines and their receptors will eventually lead to improved treatment strategies in the clinical management of IgE-mediated allergy.
免疫球蛋白E(IgE)的发现被认为是迄今为止临床过敏领域最重要的贡献。对啮齿动物和人类的研究表明,IgE的产生可能受抗原特异性辅助性T细胞和抑制性T细胞以及对IgE具有亲和力的同型特异性因子的调节。近年来,已证明IgE的合成部分受细胞因子网络的调节。这篇综述总结了上调(白细胞介素-4、5和6)和下调(干扰素-γ和白细胞介素-2)IgE产生的细胞因子。重点放在白细胞介素-4和干扰素-γ这两种已知在IgE合成中起主要但相反作用的淋巴因子上。对细胞因子及其受体控制IgE的各种机制的深入了解最终将导致IgE介导的过敏临床管理中治疗策略的改进。